Browsing by Author Sala, A
Showing results 1 to 20 of 29
next >
Issue Date | Title | Author(s) |
---|---|---|
16-Feb-2020 | ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma | Andersson, MK; Mangiapane, G; Nevado, PT; Tsakaneli, A; Carlsson, T; Corda, G; Nieddu, V; Abrahamian, C; Chayka, O; Rai, L; Wick, M; Kedaigle, A; Stenman, G; Sala, A |
2012 | A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma | Sottile, F; Gnemmi, I; Cantilena, S; D'Acunto, WC; Sala, A |
2009 | Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas | Chakya, O; Corvetta, D; Dews, M; Caccamo, AE; Piotrowska, I; Santilli, G; Gibson, S; Sebire, NJ; Himoudi, N; Hogarty, MD; Anderson, J; Bettuzzi, S; Thomas-Tikhonenko, A; Sala, A |
2016 | Cutaneous cylindroma: it's all about MYB | Corda, G; Sala, A |
13-May-2015 | Editorial: Targeting MYCN in pediatric cancers | Sala, A |
2019 | Engineered human mesenchymal stem cells for neuroblastoma therapeutics | Karteris, E; Nieddu, V; Piredda, R; Bexel, D; Barton, J; Anderson, J; Sebire, N; Kolluri, K; Janes, SM; Sala, A |
3-Sep-2022 | Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles | Ragusa, D; Cicirò, Y; Federico, C; Saccone, S; Bruno, F; Saeedi, R; Sisu, C; Pina, C; Sala, A; Tosi, S |
14-Aug-2024 | EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate | Bibbò, S; Capone, E; Lovato, G; Lamolinara, A; Ponziani, S; Iezzi, M; Lattanzio, R; Mazzocco, K; Morini, M; Giansanti, F; De Laurenzi, V; Whitfield, J; Iacobelli, S; Ippoliti, R; Beaulieu, ME; Soucek, L; Sala, A; Sala, G |
23-Feb-2024 | Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies | Cicirò, Y; Ragusa, D; Sala, A |
2015 | Frizzled receptor 6 and risk of metastatic recurrence in early triple negative breast cancer | Corda, Gabriele |
2011 | Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas | Cantilena, S; Pastorino, F; Pezzolo, A; Chayka, O; Pistoia, V; Ponzoni, M; Sala, A |
9-Nov-2016 | Functional and prognostic significance of the genomic amplification of frizzled receptor 6 ( FZD6 ) in breast cancer | Corda, G; Sala, G; Lattanzio, R; Iezzi, M; Sallese, M; Fragassi, G; Lamolinara, A; Mirza, H; Barcaroli, D; Ermler, S; Silva, E; Yasaei, H; Newbold, RF; Vagnarelli, P; Mottolese, M; Natali, PG; Perracchio, L; Quist, J; Grigoriadis, A; Marra, P; Tutt, AN; Piantelli, M; Iacobelli, S; De Laurenzi, V; Sala, A |
2017 | Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma | Sala, A |
2015 | Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells | Chayka, O; D'Acunto, CW; Middleton, O; Arab, M; Sala, A |
30-Jun-2021 | Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved Survival | Tagalakis, AD; Jayarajan, V; Maeshima, R; Ho, KH; Syed, F; Wu, L-P; Aldossary, AM; Munye, MM; Mistry, T; Ogunbiyi, OK; Sala, A; Standing, JF; Moghimi, SM; Stoker, AW; Hart, SL |
2020 | Investigating the role of exosomes in MYCN tumourigenesis and neuroblastoma | - |
2023 | Investigating the role of the MYB-BUB1 axis in adenoid cystic carcinoma | Cicirò, Ylenia |
19-Dec-2023 | The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma | Cicirò, Y; Ragusa, D; Nevado, PT; Lattanzio, R; Sala, G; Des Rochers, T; Millard, M; Andersson, M; Stenman, G; Sala, A |
2021 | Modelling the t(7;12) leukaemia using gene editing technology | Ragusa, Denise |
26-Feb-2021 | MYB oncoproteins: emerging players and potential therapeutic targets in human cancer | Cicirò, Y; Sala, A |